LAVAL, QUEBEC–(Marketwired – Aug. 4, 2015) – ProMetic Life Sciences Inc. (TSX:PLI)(OTCQX:PFSCF), (“ProMetic” or the “Corporation”) announced today that an orphan drug designation status has been granted for its human […]
https://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.png00Marketwiredhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngMarketwired2015-08-04 03:00:002015-08-05 20:25:47European Commission Grants Orphan Drug Designation to ProMetic’s Plasma-Derived Plasminogen Drug
